VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Minocycline-EDTA
Preclinical
Small molecule
M
M.D. Anderson Cancer Center
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Catheter-Related Infections
Withdrawn
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Catheter-Related Infections
Preclinical
Withdrawn
Clinical
Trials by Indication
[1]
Catheter-Related Infections
1 trial
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
Withdrawn
·
M
M.D. Anderson Cancer Center
·
N/A
·
NCT00378781
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Minocycline-EDTA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Minocycline-EDTA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Minocycline-EDTA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
M.D. Anderson Cancer Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
M
M.D. Anderson Cancer Center
Related News